Detalles de la búsqueda
1.
Novel insights into negative pressure wound healing from an in situ porcine perspective.
Wound Repair Regen
; 30(1): 64-81, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34618990
2.
Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections.
Antimicrob Agents Chemother
; 64(4)2020 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31932379
3.
Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients.
Clin Infect Dis
; 64(5): 605-613, 2017 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28011602
4.
Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia.
Antimicrob Agents Chemother
; 61(5)2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28264856
5.
Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia.
J Antimicrob Chemother
; 72(2): 535-542, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27999028
6.
Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia.
Antimicrob Agents Chemother
; 60(5): 3070-5, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26953202
7.
Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients.
Clin Infect Dis
; 61(6): 871-8, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26063715
8.
Evaluation of ceftaroline activity against heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-intermediate methicillin-resistant S. aureus strains in an in vitro pharmacokinetic/pharmacodynamic model: exploring the "seesaw effect".
Antimicrob Agents Chemother
; 57(6): 2664-8, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23545533
9.
Reply to Chanderraj et al.
Clin Infect Dis
; 65(8): 1427-1428, 2017 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29017243
10.
Evaluation of telavancin activity versus daptomycin and vancomycin against daptomycin-nonsusceptible Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
Antimicrob Agents Chemother
; 56(2): 955-9, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22123693
11.
Evaluation of ceftaroline activity versus ceftriaxone against clinical isolates of Streptococcus pneumoniae with various susceptibilities to cephalosporins in an in vitro pharmacokinetic/pharmacodynamic model.
Antimicrob Agents Chemother
; 56(5): 2691-5, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22354289
12.
Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus using an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
Antimicrob Agents Chemother
; 56(11): 5709-14, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22908167
13.
Daptomycin-nonsusceptible vancomycin-intermediate staphylococcus aureus vertebral osteomyelitis cases complicated by bacteremia treated with high-dose daptomycin and trimethoprim-sulfamethoxazole.
Antimicrob Agents Chemother
; 56(11): 5990-3, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22869580
14.
Evaluation of standard- and high-dose daptomycin versus linezolid against vancomycin-resistant Enterococcus isolates in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Antimicrob Agents Chemother
; 56(6): 3174-80, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22470111
15.
Impact of dose de-escalation and escalation on daptomycin's pharmacodynamics against clinical methicillin-resistant Staphylococcus aureus isolates in an in vitro model.
Antimicrob Agents Chemother
; 55(5): 2160-5, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21321148
16.
Characterizing vancomycin-resistant Enterococcus strains with various mechanisms of daptomycin resistance developed in an in vitro pharmacokinetic/pharmacodynamic model.
Antimicrob Agents Chemother
; 55(10): 4748-54, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21788457
17.
Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.
Antimicrob Agents Chemother
; 54(12): 5187-92, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20921318
18.
Activity of pulmonary vancomycin exposures versus planktonic and biofilm isolates of methicillin-resistant Staphylococcus aureus from cystic fibrosis sputum.
Int J Antimicrob Agents
; 55(4): 105898, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-31931147
19.
Evaluation of the INCREMENT-CPE, Pitt Bacteremia and qPitt Scores in Patients with Carbapenem-Resistant Enterobacteriaceae Infections Treated with Ceftazidime-Avibactam.
Infect Dis Ther
; 9(2): 291-304, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32088843
20.
Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections.
Open Forum Infect Dis
; 6(12): ofz522, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31890725